- £281.55m
- £256.65m
- £36.80m
- 77
- 14
- 83
- 61
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.6 | 23.9 | 27.9 | 31.3 | 36.8 |
Cost of Revenue | |||||
Gross Profit | 25.5 | 16.3 | 19 | 22.2 | 26.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 98.4 | 41.2 | 32.2 | 29.5 | 32.2 |
Operating Profit | -63.8 | -17.3 | -4.3 | 1.8 | 4.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -27.6 | -18.4 | -2.1 | 10.5 | 4.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.8 | -26.8 | 2.3 | 14.1 | 9.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -48.3 | -33.5 | 3.6 | 16.1 | 10.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -48.3 | -33.5 | 3.6 | 16.1 | 10.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.076 | -0.068 | 0.005 | 0.032 | 0.021 |
Dividends per Share | |||||
Special Dividends per Share |